These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 30098312
1. Pharmacological blockade of fatty acid amide hydrolase (FAAH) by URB597 improves memory and changes the phenotype of hippocampal microglia despite ethanol exposure. Rivera P, Fernández-Arjona MDM, Silva-Peña D, Blanco E, Vargas A, López-Ávalos MD, Grondona JM, Serrano A, Pavón FJ, Rodríguez de Fonseca F, Suárez J. Biochem Pharmacol; 2018 Nov; 157():244-257. PubMed ID: 30098312 [Abstract] [Full Text] [Related]
2. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization. Grieco M, De Caris MG, Maggi E, Armeli F, Coccurello R, Bisogno T, D'Erme M, Maccarrone M, Mancini P, Businaro R. Int J Mol Sci; 2021 Jul 19; 22(14):. PubMed ID: 34299330 [Abstract] [Full Text] [Related]
3. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. Murphy N, Cowley TR, Blau CW, Dempsey CN, Noonan J, Gowran A, Tanveer R, Olango WM, Finn DP, Campbell VA, Lynch MA. J Neuroinflammation; 2012 Apr 26; 9():79. PubMed ID: 22537429 [Abstract] [Full Text] [Related]
4. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. J Pharmacol Exp Ther; 2005 Apr 26; 313(1):352-8. PubMed ID: 15579492 [Abstract] [Full Text] [Related]
5. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C. Anesth Analg; 2019 Aug 26; 129(2):587-597. PubMed ID: 29863609 [Abstract] [Full Text] [Related]
6. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. Starowicz K, Makuch W, Korostynski M, Malek N, Slezak M, Zychowska M, Petrosino S, De Petrocellis L, Cristino L, Przewlocka B, Di Marzo V. PLoS One; 2013 Aug 26; 8(4):e60040. PubMed ID: 23573230 [Abstract] [Full Text] [Related]
7. Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum. Rivera P, Silva-Peña D, Blanco E, Vargas A, Arrabal S, Serrano A, Pavón FJ, Bindila L, Lutz B, Rodríguez de Fonseca F, Suárez J. Neuropharmacology; 2019 Mar 01; 146():184-197. PubMed ID: 30496754 [Abstract] [Full Text] [Related]
9. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK. Br J Pharmacol; 2013 Oct 01; 170(3):489-505. PubMed ID: 23347118 [Abstract] [Full Text] [Related]
12. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB. J Psychopharmacol; 2019 May 01; 33(5):606-614. PubMed ID: 30789299 [Abstract] [Full Text] [Related]
13. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V. Br J Pharmacol; 2012 Oct 01; 167(3):627-40. PubMed ID: 22595021 [Abstract] [Full Text] [Related]
14. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity. Shoshan N, Segev A, Abush H, Mizrachi Zer-Aviv T, Akirav I. Hippocampus; 2017 Oct 01; 27(10):1093-1109. PubMed ID: 28667676 [Abstract] [Full Text] [Related]
15. The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy. Slusar JE, Cairns EA, Szczesniak AM, Bradshaw HB, Di Polo A, Kelly ME. Neuropharmacology; 2013 Sep 01; 72():116-25. PubMed ID: 23643752 [Abstract] [Full Text] [Related]
16. Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model. Nazıroğlu M, Taner AN, Balbay E, Çiğ B. Mol Cell Biochem; 2019 Mar 01; 453(1-2):143-155. PubMed ID: 30159798 [Abstract] [Full Text] [Related]
17. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors. Stern CAJ, da Silva TR, Raymundi AM, de Souza CP, Hiroaki-Sato VA, Kato L, Guimarães FS, Andreatini R, Takahashi RN, Bertoglio LJ. Neuropharmacology; 2017 Oct 01; 125():220-230. PubMed ID: 28754373 [Abstract] [Full Text] [Related]
20. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. Murillo-Rodríguez E, Vázquez E, Millán-Aldaco D, Palomero-Rivero M, Drucker-Colin R. Eur J Pharmacol; 2007 May 07; 562(1-2):82-91. PubMed ID: 17336288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]